Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia

Anti-melanoma differentiation-associated protein 5 (anti-MDA5) associated clinically amyopathic dermatomyositis (CADM) is an extremely rare disease associated with significantly higher morbidity and mortality compared to other inflammatory myopathies.This report describes a unique case of a patient who presented with an acute interstitial pneumonia and rapidly progressing respiratory failure due to an undiagnosed anti-MDA5 amyopathic dermatomyositis, without any of the typical dermatomyositis symptoms or physical exam findings.Diagnosis of anti-MDA5 amyopathic dermatomyositis is challenging and standardized treatments for this disease have not been fully developed, which highlights the importance of multidisciplinary approach and collaboration between medical centres.

Authors

Institutions

Publication Details

Journal
European Journal of Case Reports in Internal Medicine
Published
2024-11-29
DOI
https://doi.org/10.12890/2024_005036
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia

Inita Buliņa, Kristīne Ivanova, Zaiga Kravale, Dace Žentiņa et al.
European Journal of Case Reports in Internal Medicine
Inflammatory Myopathies and Dermatomyositis
article

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia

Inita Buliņa, Kristīne Ivanova, Zaiga Kravale, Dace Žentiņa, Darija Logvinova
article en

Abstract

Anti-melanoma differentiation-associated protein 5 (anti-MDA5) associated clinically amyopathic dermatomyositis (CADM) is an extremely rare disease associated with significantly higher morbidity and mortality compared to other inflammatory myopathies.This report describes a unique case of a patient who presented with an acute interstitial pneumonia and rapidly progressing respiratory failure due to an undiagnosed anti-MDA5 amyopathic dermatomyositis, without any of the typical dermatomyositis symptoms or physical exam findings.Diagnosis of anti-MDA5 amyopathic dermatomyositis is challenging and standardized treatments for this disease have not been fully developed, which highlights the importance of multidisciplinary approach and collaboration between medical centres.

European Journal of Case Reports in Internal MedicineVol. 12(1)
Pauls Stradiņš Clinical University Hospital (LV), Riga Stradiņš University (LV)
Good health and well-being
Openalex Percentile: Top 67%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia — Inita Buliņa, Kristīne Ivanova, et al. · European Journal of Case Reports in Internal Medicine (2024) | TGRS Research Map | TGRS